Close

Merrimack Pharma (MACK) Announces Final Phase 3 NAPOLI-1 Study Results; Previous OS Advantage Maintained

Go back to Merrimack Pharma (MACK) Announces Final Phase 3 NAPOLI-1 Study Results; Previous OS Advantage Maintained
MERRIMACK PHARM (NASDAQ: MACK) Delayed: 14.75 --0 (-0%)
Previous Close $14.75    52 Week High $9.63 
Open $14.75    52 Week Low $4.39 
Day High $14.75    P/E N/A 
Day Low $14.75    EPS $-1.24 
Volume 700       

ShangPharma Corp. ADS (NYSE: SHP) Delayed: 8.95 --0 (-0%)
Previous Close $8.95    52 Week High $26.30 
Open $8.95    52 Week Low $26.03 
Day High $8.95    P/E N/A 
Day Low $8.95    EPS $0.00 
Volume 1,942,335       

Shire pic (NASDAQ: SHPG) Delayed: 179.20 +101.90 (131.82%)
Previous Close $77.30    52 Week High $219.52 
Open $77.29    52 Week Low $147.60 
Day High $77.49    P/E N/A 
Day Low $179.20    EPS $0.00 
Volume 302,425